Lir Therapeutics at ESGCT 2026
Oct 27–30, 2026 Hamburg, Germany ~2.5k attendees Website
Lir Therapeutics brings 2 presentations to ESGCT 2026 in Hamburg. Its work centres on designing AAV capsids with machine learning tied to laboratory testing. It covers capsids built to evade pre-existing antibodies and active learning strategies that choose which designs to test next.
| Organization | ESGCT 2026 Attendance |
|---|---|
Lir Therapeutics London, UK | |
Designs AAV capsids and other viral vectors with an AI engine linked to its own laboratory testing. | Poster Wed Oct 28 1:30pm–3:30pm Designing antibody-evading AAVs with an AI lab-in-the-loop approach Poster Thu Oct 29 2:00pm–4:00pm Active learning strategies to optimise AI-guided AAV capsid design |
Instantly find 20 buyers from Lir Therapeutics
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by the European Society of Gene & Cell Therapy. Submit a correction